Impact News +++ Webull Announces $100 Million Share Repurchase Program (PR Newswire) +++ WEBULL Aktie +3,90%

DANAHER Aktie

>DANAHER Aktienkurs

169.5 EUR +2.2% (TradegateBSX)

Ask: 168.5 EUR / 33 Stück

Bid: 167.25 EUR / 33 Stück

Tagesumsatz: 1456 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

DANAHER Aktie über LYNX handeln

Intraday

1 Jahr

>DANAHER Performance

1 Woche: -0,4%

1 Monat: +1,6%

3 Monate: -16,9%

6 Monate: -7,4%

1 Jahr: +0,2%

laufendes Jahr: -15,4%

>DANAHER Aktie

Name:

DANAHER CORP. DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US2358511028 / 866197

Symbol/ Ticker:

DAP (Frankfurt) / DHR (NYSE)

Kürzel:

FRA:DAP, ETR:DAP, DAP:GR, NYSE:DHR

Index:

S&P500

Webseite:

https://www.danaher.com/

Profil:

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services globally, with a primary focus on the United States, China, and other international markets. Operating through three key segm..
>Volltext..

Marktkapitalisierung:

117156.34 Mio. EUR

Unternehmenswert:

130017.89 Mio. EUR

Umsatz:

20883.79 Mio. EUR

EBITDA:

6544.46 Mio. EUR

Nettogewinn:

3072.05 Mio. EUR

Gewinn je Aktie:

4.32 EUR

Schulden:

16742.39 Mio. EUR

Liquide Mittel:

3922.94 Mio. EUR

Operativer Cashflow:

5453.86 Mio. EUR

Bargeldquote:

0.68

Umsatzwachstum:

-9.3%

Gewinnwachstum:

-18.3%

Dividende je Aktie:

1.17 EUR

Dividendenrendite:

0.7%

Dividendenschätzung:

0.82%

Div. Historie:

27.03.26 - 0.3472€
29.12.25 - 0.27174398€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

DANAHER

Letzte Datenerhebung:

21.04.26

>DANAHER Kennzahlen

Aktien/ Unternehmen:

Aktien: 707.7 Mio. St.

Frei handelbar: 91.14%

Leerverk. Aktien: 0.98%

Rückkaufquote: 2.18%

Mitarbeiter: 60000

Umsatz/Mitarb.: 0.35 Mio. EUR

Analysten:

Analystenrating: Strong buy

Kursziel: 30.05%

Bewertung:

KGV: 38.59

KGV lG: 23.27

KUV: 5.61

KBV: 2.62

PEG-Ratio: -

EV/EBITDA: 19.87

Rentabilität:

Bruttomarge: 61.4%

Gewinnmarge: 14.65%

Operative Marge: 21.38%

Managementeffizenz:

Gesamtkaprendite: 4.47%

Eigenkaprendite: 7.05%

>DANAHER Anleihen

>DANAHER Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>DANAHER Chart & Kurs - NYSE

>DANAHER News

21.04.26 - 14:30	Danaher (DHR) Q1 Earnings Beat Estimates (Zacks)
	Danaher (DHR) delivered earnings and revenue surprises of +5.92% and -0.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?...

21.04.26 - 13:51	AKTIEN IM FOKUS: Zahlen und Ausblick von Danaher treiben Merck und Sartorius an (DPA-AFX)
	FRANKFURT (dpa-AFX) - Solide Zahlen des Diagnostik- und Biotechnologiekonzerns Danaher sind am deutschen Aktienmarkt am Dienstag gut angekommen. Mit den Aktien von Merck KGaA (Merck) ......

21.04.26 - 13:36	Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains (WSJ EN)
	Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit momentum in its Biotechnology and Life Sciences segments....

21.04.26 - 13:12	Danaher Increases 2026 Adj. Earnings Guidance (AFX)
	WASHINGTON (dpa-AFX) - Danaher (DHR) increased full year adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55 from previous guidance of $8.35 to $8.50. For full yea......

21.04.26 - 13:09	Danaher rises after lifting full-year earnings outlook (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.04.26 - 12:30	Danaher Corp. Profit Advances In Q1 (AFX)
	WASHINGTON (dpa-AFX) - Danaher Corp. (DHR) revealed earnings for its first quarter that Increases, from last yearThe company's bottom line came in at $1.029 billion, or $1.45 per share. This compa......

21.04.26 - 12:24	Danaher falls on revenue miss despite earnings beat (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

21.04.26 - 12:24	Earnings Snapshot: Danaher tops Q1 earnings targets, lifts FY26 guidance despite slight revenue miss (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.04.26 - 12:06	Danaher Non-GAAP EPS of $2.06 beats by $0.12, revenue of $5.95B misses by $50M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

21.04.26 - 12:03	Danaher Reports First Quarter 2026 Results (PR Newswire)
	WASHINGTON, April 21, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2026. All results in this release reflect only continuing operations and period-to-period comparisons are year-over-year unless otherwise noted. Key First Quarter 2026......

21.04.26 - 10:00	United Airlines legt jetzt nach (MarktEinblicke)
	Am Dienstag werden Anleger auf die Zahlen bei 3M, Danaher, GE Aerospace, Halliburton, Northrop Grumman, UnitedHealth, United Airlines schauen. The post United Airlines legt jetzt nach first appeared on marktEINBLICKE....

16.04.26 - 18:15	Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock? (Zacks)
	DHR heads into Q1 results with rising bioprocessing demand and steady estimates, but cost pressures and FX headwinds could weigh on performance....

15.04.26 - 09:03	Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration (PR Newswire)
	Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research SUNNYVALE, Calif. and OXFORD, England, April 15, 2026 /PRNewswire/ -- Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, and Oxford......

14.04.26 - 17:30	Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week′s Release (Zacks)
	Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations....

13.04.26 - 16:03	Abcam launches SimpleStep Ignite™ ELISA: an innovative assay platform that combines 50x higher sensitivity and up to 35x wider dynamic range in only 55 minutes (PR Newswire)
	CAMBRIDGE, England, April 13, 2026 /PRNewswire/ -- Abcam, a Danaher company and a global provider of validated antibodies and assay solutions, today announced SimpleStep Ignite™ ELISA, a next generation chemiluminescent immunoassay platform designed for scientists who need faster and......

13.04.26 - 09:03	Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes (PR Newswire)
	Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April 13, 2026 /PRNewswire/ -- Beckman Coulter Diagnostics, a Danaher company and global leader in......

10.04.26 - 00:51	Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire)
	Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses. Shareholders should contact the......

06.04.26 - 15:18	What to Expect From Danaher Corporation's Q1 2026 Earnings Report (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

26.03.26 - 23:42	XETR: DIVIDEND/INTEREST INFORMATION - 27.03.2026 - US2358511028 (XETRA)
	Das Instrument DAP US2358511028 DANAHER CORP. DL-,01 EQUITY wird ex Dividende/Zinsen gehandelt am 27.03.2026 The instrument DAP US2358511028 DANAHER CORP. DL-,01 EQUITY has its ex-dividend/interest day on 27.03.2026...

23.03.26 - 17:12	Leica Biosystems Solidifies Leadership in Digital Pathology with Launch of Next-Generation Aperio GT Elite Scanner and Aperio iQC Software (PR Newswire)
	VISTA, Calif., March 23, 2026 /PRNewswire/ -- Leica Biosystems, a Danaher Company and a global leader in anatomic pathology solutions, continues to enhance digital pathology workflows with the US launch of the Aperio GT EliteTM scanner, along with Aperio iQC software incorporating unique......

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Quid sit futurum cras, fuge quaerere! - Forsche nicht danach, was morgen sein wird! - Quintus Flaccus Horaz

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram